Thalidomide-based Regimens for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-analysis

Thalidomide-based Regimens for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-analysis

Background: Thalidomide is an immunomodulatory and anti-angiogenic drug that has shown promise in patients with myeloma. Trials comparing efficacy of standard melphalan and prednisone (MP) therapy with MP plus thalidomide (MPT) in transplant-ineligible or elderly patients with multiple myeloma (MM)...

Full description

Bibliographic Details
Main Authors: Wen-Wen Lyu, Qing-Chun Zhao, De-Hai Song, Jin-Jie Zhang, Zhao-Xing Ding, Bao-Yuan Li, Chuan-Mei Wei
Format: Article
Language:English
Published: Wolters Kluwer 2016-01-01
Series:Chinese Medical Journal
Subjects:
Elderly; Meta-analysis; Multiple Myeloma; Thalidomide
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=3;spage=320;epage=325;aulast=Lyu

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=3;spage=320;epage=325;aulast=Lyu

Similar Items